The Methylene Blue Comeback
Methylene blue, a grandfather drug, is making a comeback in Africa due to the resistance of plasmodium to quinines. It is also being used to protect the brain during chemotherapy interventions. However, the FDA does not acknowledge these uses as there is no pharmaceutical company willing to invest in a non-patentable drug like methylene blue.In this clip
From this podcast
The Peter Attia Drive Podcast
#38–Francisco Gonzalez-Lima, Ph.D.: Alzheimer’s disease & the vascular hypothesis
Related Questions